Paxlovid: A Regulatory Gamble

Am J Med. 2023 Apr;136(4):336-338. doi: 10.1016/j.amjmed.2022.12.017. Epub 2023 Jan 3.

Authors

Miloš D Miljković¹, Vinay Prasad²

Affiliations

¹ Cartesian Therapeutics, Gaithersburg, Md.
² Department of Epidemiology and Biostatistics; Department of Medicine, University of California, San Francisco. Electronic address: vinayak.prasad@ucsf.edu.

PMID: 36608747
DOI: 10.1016/j.amjmed.2022.12.017

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Gambling*
Humans
Quality of Life

Substances

nirmatrelvir and ritonavir drug combination